Salinex Drops
Natural health product licensed in Canada
- Licence holder
- Exzell Pharma Inc.
- NPN or DIN-HM
- 80024901
- Status
- Active licence
- Licence date
- 21 April 2011
- Revision date
- 5 September 2023
- Form
- Gouttes nasales
- Route of administration
- Nasale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Chlorure de benzalkonium, Glycérine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | maximum: 2 years | 4 Goutte(s) | minimum: 1 Tous les jours ; maximum: 6 Tous les jours |
| Enfants | minimum: 3 years | minimum: 1 mL ; maximum: 2 mL | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Promotes nasal and sinus drainage. Helps reduce symptoms of dry irritated nose. Helps maintain healthy sinuses.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80024901
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging